Back to News
Market Impact: 0.2
Wall Street Analysts See a 214.55% Upside in Regenxbio (RGNX): Can the Stock Really Move This High?
Source: zacks.com
Analyst InsightsAnalyst EstimatesCompany Fundamentals
Wall Street analysts’ average price target for Regenxbio (RGNX) implies 214.6% potential upside, though the article cautions that this metric’s effectiveness is questionable. Positive earnings estimate revisions may also support upside, but no realized stock move or forecast figures are provided.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.20
Ticker Sentiment
RGNX0.20
More News
- NextDC shares surge 43% after Goodman, Digital Realty stake purchases
- Snap shares fall over 10% on third-quarter earnings miss
- Softbank’s $5.4 bln takeover of ABB robotics unit blocked by China- FT
- Qualcomm issues disappointing earnings forecast as memory shortage weighs on smartphone sales
- Drone Attacks Spawn New Insurance Market in Baltics, Poland
- REA Group shares rally on strong Q1 revenue